Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study

Published:2021-03-14 Issue:8 Volume:35 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Fujita Y.¹²^ORCID,Nohara T.¹,Takashima S.¹^ORCID,Natsuga K.¹^ORCID,Adachi M.³,Yoshida K.³,Shinkuma S.⁴^ORCID,Takeichi T.⁵^ORCID,Nakamura H.¹^ORCID,Wada O.⁶,Akiyama M.⁵^ORCID,Ishiko A.³,Shimizu H.¹^ORCID

Affiliation:

1. Department of Dermatology Hokkaido University Graduate School of Medicine and Faculty of Medicine Sapporo Japan

2. Department of Dermatology Sapporo City General Hospital Sapporo Japan

3. Department of Dermatology Toho University School of Medicine Tokyo Japan

4. Department of Dermatology Nara Medical University School of Medicine Kashihara Japan

5. Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan

6. Life Science Institute Inc. Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17201

Reference10 articles.

1. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

2. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa

3. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial

4. Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural reconstruction of mouse acute aortic dissection by intravenously administered human Muse cells without immunosuppression;Communications Medicine;2024-09-09

2. Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial;Stem Cell Research & Therapy;2024-08-13

3. Human post-implantation blastocyst-like characteristics of Muse cells isolated from human umbilical cord;Cellular and Molecular Life Sciences;2024-07-11

4. Human post-implantation blastocyst-like characteristics of Muse cells isolated from human umbilical cord;2024-06-20

5. Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment;Stem Cells Translational Medicine;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3